Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut, Lebanon.
Anal Cell Pathol (Amst). 2020 Apr 16;2020:2097214. doi: 10.1155/2020/2097214. eCollection 2020.
Vascular endothelial growth factors (VEGFs) consist of five molecules (VEGFA through D as well as placental growth factor) which are crucial for regulating key cellular and tissue functions. The role of VEGF and its intracellular signaling and downstream molecular pathways have been thoroughly studied. Activation of VEGF signal transduction can be initiated by the molecules' binding to two classes of transmembrane receptors: (1) the VEGF tyrosine kinase receptors (VEGF receptors 1 through 3) and (2) the neuropilins (NRP1 and 2). The involvement of Rho GTPases in modulating VEGFA signaling in both cancer cells and endothelial cells has also been well established. Additionally, different isoforms of Rho GTPases, namely, RhoA, RhoC, and RhoG, have been shown to regulate VEGF expression as well as blood vessel formation. This review article will explore how Rho GTPases modulate VEGF signaling and the consequences of such interaction on cancer progression.
血管内皮生长因子 (VEGFs) 由五个分子组成(VEGFA 到 D 以及胎盘生长因子),它们对调节关键的细胞和组织功能至关重要。VEGF 及其细胞内信号转导和下游分子途径的作用已经得到了深入研究。VEGF 信号转导的激活可以通过分子与两类跨膜受体的结合来启动:(1)VEGF 酪氨酸激酶受体(VEGF 受体 1 到 3)和(2)神经纤毛蛋白(NRP1 和 2)。Rho GTPases 在调节癌细胞和内皮细胞中 VEGFA 信号转导中的作用也得到了很好的证实。此外,不同的 Rho GTPases 同工型,即 RhoA、RhoC 和 RhoG,已被证明可调节 VEGF 的表达和血管形成。本文综述了 Rho GTPases 如何调节 VEGF 信号转导,以及这种相互作用对癌症进展的影响。